冠科美博 (Apollomics Inc.) 扩充其领导团队，任命 Jane Wang 博士担任首席科学官一职
Jul 26, 2022 09:19 HKT |  |
|
冠科美博 (Apollomics Inc.) 擴充其領導團隊，任命 Jane Wang 博士擔任首席科學官一職
Jul 26, 2022 09:18 HKT | |
|
Apollomics Inc. Expands Leadership Team with Appointment of Jane Wang, PhD as Chief Scientific Officer
Jul 26, 2022 09:17 HKT | |
|
Novotech 的灵活工作政策入围最佳工作场所灵活性计划“2022 年卓越奖”
Jul 25, 2022 21:00 HKT |  |
|
Novotech 的靈活工作政策入圍最佳工作場所靈活性計劃“2022 年卓越獎”
Jul 25, 2022 21:00 HKT | |
|
Novotech's Flexible Work Policy is Finalist in Best Workplace Flexibility Program "Excellence Award 2022"
Jul 25, 2022 09:00 HKT | |
|
TrialWire Technology Platform Rolls Out World First SMS/Text Patient Contact System Across all Studies Globally
Jul 20, 2022 09:00 HKT |  |
|
노보텍과 엔드포인트, “중국의 세포 및 유전자 치료의 진화: 범용성 CAR-T 사례”에 관해 발표
Jul 19, 2022 18:00 HKT | |
|
Therapeutic Goods Administration Grants Provisional Approval for Moderna's COVID-19 Vaccine in Children Aged Six Months to Five Years
Jul 19, 2022 11:00 HKT |  |
|
Novotech和Endpoints展示“中国细胞和基因治疗的演变：通用CAR-T的案例”
Jul 19, 2022 07:00 HKT | |
|
Novotech和Endpoints展示“中國細胞和基因治療的演變：通用CAR-T的案例”
Jul 19, 2022 07:00 HKT | |
|
Novotech and Endpoints Present "Evolution of Cell & Gene Therapy in China: The Case for Universal CAR-T"
Jul 18, 2022 16:00 HKT | |
|
TrialWire(TM) 技术平台宣布基于成功的患者招募计划
Jul 18, 2022 15:00 HKT | |
|
TrialWire(TM) 技術平台宣布基於成功的患者招募計劃
Jul 18, 2022 15:00 HKT | |
|
TrialWire Technology Platform Announces Success-based Patient Recruitment Plan
Jul 18, 2022 15:00 HKT | |
|
노보텍 고객사 SK바이오사이언스, 스카이코비원(SKYCovione(TM)) 코로나19 백신 국내 승인
Jul 14, 2022 20:00 HKT | |
|
Novotech 客户 SK bioscience 在韩国获得 SKYCovione(TM) COVID-19 疫苗批准
Jul 14, 2022 08:00 HKT | |
|
Novotech 客戶 SK bioscience 在韓國獲得 SKYCovione(TM) COVID-19 疫苗批准
Jul 14, 2022 08:00 HKT | |
|
Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea
Jul 13, 2022 14:30 HKT | |
|
노보텍, 2022 코리아 바이오프로세싱 엑설런스 어워드에서 ‘2022년 최고 바이오로직스 CRO 어워드’ 수상
Jun 29, 2022 19:00 HKT | |
|